NYLI Candriam U.S. Mid Cap Equity ETF Rating $39.46 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock NYLI Candriam U.S. Mid Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IQSM Aggregate RatingModerate Buy 2.77Holdings in IQSM have an aggregate rating of Moderate Buy based on 441 analyst ratings issued in the past year covering 25 companies (19.6% of the portfolio).IQSM Aggregate Price Target$39.46High Prediction$39.46Average Prediction$39.46Low Prediction$39.46Holdings in IQSM have an aggregate price target of $39.46 and a range of $39.46 to $39.46 covering 25 companies (19.6% of the portfolio).IQSM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by NYLI Candriam U.S. Mid Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IQSM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.19%RVMDRevolution Medicines$189.241.9097 of 5 stars3.00$135.39 -28.5%22News CoverageAnalyst ForecastInsider Trade1.01%NVTnVent Electric$152.29+0.1%4.8518 of 5 stars3.07$189.50 24.4%15Positive NewsGap Up0.97%MKSIMKS$365.564.1263 of 5 stars2.88$374.07 2.3%16Analyst ForecastGap Up0.96%TWLOTwilio$209.31+0.0%3.2256 of 5 stars2.92$207.41 -0.9%25Analyst ForecastInsider Trade0.93%MTSIMACOM Technology Solutions$322.263.5415 of 5 stars2.93$335.00 4.0%14Positive NewsGap Up0.87%STRLSterling Infrastructure$700.753.3116 of 5 stars3.13$720.67 2.8%8Analyst DowngradeGap Up0.87%USFDUS Foods$104.04-0.2%2.6773 of 5 stars2.69$105.50 1.4%13News CoverageAnalyst DowngradeGap Down0.85%BURLBurlington Stores$313.49+0.1%3.809 of 5 stars2.75$353.56 12.8%200.84%FFIVF5$408.143.518 of 5 stars2.58$382.67 -6.2%12News CoveragePositive NewsGap Up0.81%CHRWC.H. Robinson Worldwide$189.854.0356 of 5 stars2.65$195.35 2.9%23News CoverageAnalyst Forecast0.78%MRNAModerna$79.761.1697 of 5 stars1.83$37.13 -53.4%18Gap Down0.78%SNXTD SYNNEX$244.82+0.1%4.9712 of 5 stars3.00$294.67 20.4%10Positive NewsAnalyst UpgradeGap Up0.75%OKTAOkta$141.423.6644 of 5 stars2.71$116.83 -17.4%410.74%LSCCLattice Semiconductor$136.533.8543 of 5 stars3.00$130.86 -4.2%15Positive NewsGap Up0.71%VTRSViatris$16.703.0203 of 5 stars2.57$17.50 4.8%7News CoverageGap Down0.70%GHGuardant Health$167.981.8458 of 5 stars2.96$147.32 -12.3%24Analyst ForecastInsider TradeGap Up0.68%KIMKimco Realty$25.30-0.1%3.1705 of 5 stars2.53$25.71 1.6%17Positive News0.66%ONTOOnto Innovation$308.87+0.4%3.4411 of 5 stars2.92$339.60 10.0%13News CoverageGap Up0.66%ROKURoku$142.433.103 of 5 stars2.41$153.71 7.9%27Trending NewsInsider Trade0.65%BALLBall$63.35-0.1%4.3778 of 5 stars2.77$69.54 9.8%13News CoverageAnalyst Upgrade0.64%IEXIDEX$224.26+0.2%4.3795 of 5 stars2.67$241.11 7.5%90.64%ALBAlbemarle$135.27-0.2%4.6993 of 5 stars2.59$199.58 47.5%27Analyst Forecast0.63%HSTHost Hotels & Resorts$23.354.4345 of 5 stars2.71$23.95 2.6%17Positive NewsEx-DividendAnalyst Downgrade0.63%NBIXNeurocrine Biosciences$174.264.394 of 5 stars2.96$187.52 7.6%23Insider TradeGap Down0.63%NLYAnnaly Capital Management$22.55-0.1%3.4029 of 5 stars2.75$24.44 8.4%12Ex-DividendAnalyst Forecast This page (NYSEARCA:IQSM) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NYLI Candriam U.S. Mid Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share NYLI Candriam U.S. Mid Cap Equity ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IQSM Stock Alerts